Skip to main content

Jury Hears News Study Linked To Glyphosate-Cancer

Jury Hears News Study Linked To Glyphosate-Cancer

Jury Hears News Study Linked To Glyphosate-Cancer

Introduction

Jurors heard testimony about a new study, in the latest Roundup trial underway in California’s Alameda County Superior Court, involving claims filed by an elderly couple that glyphosate exposure from the popular weed killer caused them cancer.

This was the first time a compelling piece of evidence regarding glyphosate's carcinogenic nature was presented during the trial. The testimony was based on a recently published meta-analysis that glyphosate-based herbicides can increase the risk of cancer by as much as 41%. The authors of the paper analyzed all earlier studies linking glyphosate to cancer, including the Agricultural Health Study, which Monsanto frequently cited as proof of the weed killer's safety. The epidemiologist who testified for the plaintiffs said, she trusted the findings and asserted that the study published by the Agricultural Health Study was flawed as it involved data manipulation to hide glyphosate's carcinogenicity.

The couple regularly used Roundup weed killer between 1971 and 2011 and alleged that their cancer was a result of glyphosate exposure. They filed a lawsuit against Monsanto in 2017 seeking compensation for the damages. Bayer AG is facing more than 13,000 Roundup lawsuits throughout U.S. courts.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!